Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 2062321 | tert-Butyl 2-((tosyloxy)methyl)morpholine-4-carboxylate | 130546-33-7 | 98% Min. | |
| 2062318 | tert-butyl 3-bromo-5-chloro-2-fluorophenyl-carbamate | 1269232-94-1 | 98% Min. | |
| 2062310 | tert-butyl N-(4-bromo-2-methoxyphenyl)carbamate | 262433-01-2 | 98% Min. | |
| 2062302 | Thiazole-5-carboxylic acid | 14527-41-4 | 98% Min. | |
| 2062301 | tert-butyl N-[[4-[(Z)-C-chloro-N-hydroxycarbonimidoyl]phenyl]methyl]-N-methylcarbamate | 1402390-77-5 | 96% Min. | -C-chloro-N-hydroxycarbonimidoyl]phenyl]methyl]-N-methylcarbamate_1402390-77-5.png) |
| 2062035 | tert-butyl 4-[[6-[2-(quinoxaline-2-carbonylamino)phenyl]imidazo[2,1-b][1,3]thiazol-3-yl]methyl]piperazine-1-carboxylate | 925436-46-0 | 96% Min. | phenyl]imidazo[2,1-b][1,3]thiazol-3-yl]methyl]piperazine-1-carboxylate_925436-46-0.png) |
| 2062034 | tert-Butyl 4-(1-oxoisoindolin-2-yl-methyl)piperidine-1-carboxylate | 359629-19-9 | 98% Min. | piperidine-1-carboxylate_359629-19-9.png) |
| 2062024 | 4,4,5,5-tetramethyl-2-(4-propan-2-ylsulfonylphenyl)-1,3,2-dioxaborolane | 1256359-13-3 | 96% Min. | -1,3,2-dioxaborolane_1256359-13-3.png) |
| 2062011 | 2,3,5-Tri-O-benzyl-D-ribonolactone | 55094-52-5 | 96% Min. |  |
| 2061704 | Tafenoquine-d3 succinate | 1133378-83-2 | 98% Min. |  |
| Tafenoquine-d3 is a trideuerium-labeled Tafenoquine derivative. Tafenoquine, also kno | ||||
| 2061501 | TLR4-C34 | 40592-88-9 | 98% Min. |  |
| TLR4-C34 is a TLR4 inhibitor that inhibits TLR4 signaling in enterocytes and macropha | ||||
| 2061311 | TH257 | 2244678-29-1 | 98% Min. |  |
| TH257 is a Potent and selective allosteric LIMK 1/2 inhibitor. | ||||
| 2061303 | TH-263 | 313520-94-4 | 98% Min. |  |
| TH-263 is an inactive analog control for the type III allosteric LIM-kinase (LIMK) in | ||||
| S-204158 | 2,4,6-tris(4-phenylphenyl)-1,3,5-triazine | 31274-51-8 | 98% Min. |  |
| S-203041 | [4-(2,2,2-trifluoroethoxy)phenyl]boronic acid | 886536-37-4 | 95% | phenyl]boronic_acid_886536-37-4.png) |
| g scale to Kg scale may be provided. | ||||
| 2041503 | TVB-3664 | 98% Min. |  | |
| TVB-3664 is a FASN inhibitor which significantly reduces tubulin palmitoylation and m | ||||
| 193184 | TD-106 | 2250288-69-6 | >98% |  |
| TD-106 is a cereblon (CRBN) modulator, which can be used for targeted protein degrada | ||||
| 193183 | Tafamidis meglumine | 951395-08-7 | >98% |  |
| Tafamidis meglumine , also known as Fx-1006 or PF-06291826, is a drug for the amelior | ||||
| 193182 | Tafamidis | 594839-88-0 | >98% |  |
| Tafamidis, Tafamidis, also known as Fx-1006 or PF-06291826, is a drug for the amelior | ||||
| 193135 | TH287 | 1609960-30-6 | >98% |  |
| TH287 is a potent inhibitor of human 7,8-Dihydro-8-oxoguaninetriphosphatase MTH1 (NUD | ||||
| 193112 | Tinostamustine HCl | 1793059-58-1 | >98% |  |
| Tinostamustine, also known as EDO-S101, is an alkylatlng histone-deacetylase inhibito | ||||
| 19374 | Telithromycin | 191114-48-4 | >98% |  |
| Telithromycin, also known as HMR-3647 and RU-66647, is a semi-synthetic erythromycin | ||||
| 192273 | TH34 | 2196203-96-8 | >98% |  |
| TH34 is a potent HDAC6/8/10 inhibitor. TH34 induces DNA damage-mediated cell death in | ||||
| 192252 | THZ2 | 1604810-84-5 | >98% |  |
| THZ2, an analog of THZ1, with the potential to treat Triple-negative breast cancer (T | ||||
| 192145 | Tegatrabetan | 1227637-23-1 | >98% |  |
| Tegatrabetan, also known as Tegavivint and BC2059, is an orally bioavailable and pote | ||||
| 192144 | Telratolimod | 1359993-59-1 | >98% |  |
| Telratolimod, also known as 3M-052 or MEDI-9197, is a toll-like receptor 7 (TLR-7) an | ||||
| 191286 | TAS-116 | 1260533-36-5 | >98% |  |
| TAS-116 is a potent and selective inhibitor of heat shock protein 90 (Hsp90) subtypes | ||||
| 191254 | Tamibarotene | 94497-51-5 | >98% |  |
| Tamibarotene, also known as SY-1425, is an orally active, synthetic retinoid, develop | ||||
| 191123 | Tafenoquine succinate | 106635-81-8 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
| 191122 | Tafenoquine ( WR 238605 ) | 106635-80-7 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||